NeuroBo Pharmaceuticals Inc expected to post a loss of 78 cents a share - Earnings Preview

MetaVia

26/03/2024 20:15

* NeuroBo Pharmaceuticals Inc  NRBO.OQ   NRBO.O  is expected
to show no change in quarterly revenue when it reports 
results on March 28 (estimated) for the period ending December
31 2023
    * 
    * ​LSEG's mean analyst estimate for NeuroBo Pharmaceuticals
Inc is
for a loss of 78 cents per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for NeuroBo
Pharmaceuticals Inc is $36.50​, above​ its last closing price
of $4.39. ​​​

This summary was machine generated March 26 at 20:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)